[1. Cutler SJ, Scotto J, Devesa SS, Connelly RR. Third national cancer survey-an overview of available information. J Natl Cancer I 1974; 53: 1565-75.]Search in Google Scholar
[2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: Cancer J Clin 2005; 55: 74-108.10.3322/canjclin.55.2.74]Search in Google Scholar
[3. Zelefsky M, Leibel S, Gaudin P, Kutcher G, Fleshner N, Venkatramen ES, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol 1998; 41: 491-500.10.1016/S0360-3016(98)00091-1]Search in Google Scholar
[4. Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006; 24: 1990-6.10.1200/JCO.2005.05.2530]Search in Google Scholar
[5. Pollack A, Zagars GK, Starkschall G, Childress CH, Kopplin S, Boyer AL, et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol 1996; 34: 555-64.10.1016/0360-3016(95)02103-5]Search in Google Scholar
[6. De Meerleer GO, Vakaet LA, De Gersem WR, De Wagter C, De Naeyer B, De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol 2000; 47: 639-48.10.1016/S0360-3016(00)00419-3]Search in Google Scholar
[7. De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, Oosterlinck W, et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol 2004; 60: 777-87.10.1016/j.ijrobp.2004.04.017]Search in Google Scholar
[8. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol 2002; 53: 1111-6.10.1016/S0360-3016(02)02857-2]Search in Google Scholar
[9. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urology 2006; 176: 1415-9.10.1016/j.juro.2006.06.00216952647]Search in Google Scholar
[10. Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008; 89: 180-91.10.1016/j.radonc.2008.06.01318692929]Search in Google Scholar
[11. Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009; 93: 226-33.10.1016/j.radonc.2009.08.01119765846]Search in Google Scholar
[12. Wu QJ, Yoo S, Kirkpatrick JP, Thongphiew D, Yin FF. Volumetric arc intensity–modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. Int J Radiat Oncol 2009; 75:1596-604.10.1016/j.ijrobp.2009.05.00519733447]Search in Google Scholar
[13. Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother Oncol 2009; 92: 118-24.10.1016/j.radonc.2008.12.02019181409]Search in Google Scholar
[14. Bertelsen A, Hansen CR, Johansen J, Brink C. Single arc volumetric modulated arc therapy of head and neck cancer. Radiother Oncol 2010; 95: 142-8.10.1016/j.radonc.2010.01.01120188427]Search in Google Scholar
[15. Boylan CJ, Golby C, Rowbottom C. GA VMAT planning solution for prostate patients using a commercial treatment planning system. Phys Med Biol 2010; 55: N395.10.1088/0031-9155/55/14/N0120601771]Search in Google Scholar
[16. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol 2008; 72: 996-1001.10.1016/j.ijrobp.2008.02.04718455326]Search in Google Scholar
[17. Wagner D, Christiansen H, Wolff H, Vorwerk H. Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 2009; 93: 593-6.10.1016/j.radonc.2009.10.00219897266]Search in Google Scholar
[18. Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol 2010; 76: S3-9.10.1016/j.ijrobp.2009.09.040343196420171515]Search in Google Scholar
[19. Chan OS, Lee MC, Hung AW, Chang AT, Yeung RM, Lee AW. The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer–A planning study. Radiother Oncol 2011; 101: 298-302.10.1016/j.radonc.2011.08.01521907438]Search in Google Scholar
[20. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). ICRU Report 83. J ICRU 2010; 10: 1-106.10.1093/jicru/10.1.Report83]Search in Google Scholar
[21. Viani GA, Silva LGB, Stefano EJ. High-dose conformal radiotherapy reduces prostate cancer-specific mortality: results of a meta-analysis. Int J Radiat Oncol 2012; 83: e619-25.10.1016/j.ijrobp.2012.01.05122768991]Search in Google Scholar
[22. Kjaer-Kristoffersen F, Ohlhues L, Medin J, Korreman S. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 2009; 48: 227-32.10.1080/0284186080226674818855157]Search in Google Scholar
[23. Yoo S, Wu J, Lee R, Yin FF. Radiotherapy treatment plans with rapidarc for prostate cancer involving seminal vesicles and lymph nodes. Int J Radiat Oncol 2010; 76: 935-42.10.1016/j.ijrobp.2009.07.167720044214]Search in Google Scholar
[24. Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M, Mageras G. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol 2010; 76: 1456-62.10.1016/j.ijrobp.2009.03.03319540062]Search in Google Scholar
[25. Aznar MC, Petersen PM, Logadottir A, Lindberg H, Korreman SS, Kjaer-Kristoffersen F, et al. Rotational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 2010; 97: 480-4.10.1016/j.radonc.2010.09.01420970215]Search in Google Scholar
[26. Davidson MTM, Blake S, Batchelar DL, Cheung P, Mah K. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and postoperative prostate cancer. Int J Radiat Oncol 2011; 80: 1550-8.10.1016/j.ijrobp.2010.10.02421543164]Search in Google Scholar
[27. Hardcastle N, Tome WA, Foo K, Miller A, Carolan M, Metcalfe P. Comparison of prostate IMRT and VMAT biologically optimized treatment plans. Med Dosim 2011; 36: 292-8.10.1016/j.meddos.2010.06.001299584720801014]Search in Google Scholar
[28. Kopp RW, Duff M, Catalfamo F, Shah D, Rajecki M, Ahmad K. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample. Med Dosim 2011; 36: 365-72.10.1016/j.meddos.2010.09.00421377863]Search in Google Scholar
[29. Sale C, Moloney P. Dose comparisons for conformal, IMRT and VMAT prostate plans. J Med Imaging Radiat Oncol 2011; 55: 611-21.10.1111/j.1754-9485.2011.02310.x22141609]Search in Google Scholar
[30. Myerhaug S, Chan G, Craig T, Weinberg V, Cheng C, Roach M, et al. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Int J Radiat Oncol 2012; 82: e657-62.10.1016/j.ijrobp.2011.09.00622245189]Search in Google Scholar
[31. Sze HCK, Lee MCH, Hung WM, Yau TK, Lee AWM. RapidArc radiotherapy planning for prostate cancer: single-arc and double-arc techniques vs. intensity-modulated radiotherapy. Med Dosim 2012; 37: 87-91.10.1016/j.meddos.2011.01.00521925863]Search in Google Scholar
[32. Fontenot JD, King ML, Johnson SA, Wood CG, Price MJ, Lo KK. Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. Br J Radiol 2012; 85: 231-6.10.1259/bjr/94843998347400121712428]Search in Google Scholar
[33. Ishii K, Ogino R, Okada W, Nakahara R, Kawamorita R, Nakajima T. A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer. Br J Radiol 2013; 86: 20130199.10.1259/bjr.20130199379832923995872]Search in Google Scholar